Pharmaceuticals
We act for many of the world’s largest pharmaceutical companies, giving us broad and deep insights into the key trends and risks facing companies operating in the sector.
We advise on a wide range of complex cases, working with both national and international clients on high-profile and strategic matters. We have gathered significant and relevant experience of acting for leading companies in the life sciences sector on regulatory issues and we have built a track record of running a number of multi-jurisdictional matters. We also have a strong offering advising pharmaceuticals on transactions including M&A, collaborations and fundraising.
Explore our sectors
Meet our lawyers
News and insights
News: 09 February 2024
Frankfurt am Main - Allen & Overy a conseillé le groupe Sartorius sur son augmentation de capital d'un montant total de 1,4 milliard d'euros. La transaction comprenait le placement de 613 497 actions…
Publications: 21 July 2023
Le 12 juillet 2023, la Commission européenne (la Commission) a annoncé avoir sanctionné Illumina à hauteur de 432 millions d’euros ainsi que GRAIL, la cible, à une amende symbolique de 1 000 euros…
Publications: 21 July 2022
Le Tribunal de l’UE a rendu un arrêt historique ce 13 juillet 2022 en confirmant la décision de la Commission européenne (la Commission) acceptant une demande de renvoi émanant de la France (et de…